Clinical Trial: A Study of Opevesostat (MK-5684) in China Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (MK-5684-001)
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Prostatic Neoplasms
Study Type: INTERVENTIONAL
Official Title: A Phase 1 Clinical Study to Investigate the Safety and Pharmacokinetics of MK-5684 in China Participants With Metastatic Castration-Resistant Prostate Cancer
Brief Summary:
The primary objectives of this study are to evaluate the safety and tolerability of opevesostat in the treatment of male Chinese participants with metastatic castration-resistant prostate cancer (mCRPC) and to characterize the pharmacokinetic profile of opevesostat.There are no formal hypotheses to be tested in this study.
Read more